Chao-Hua Chiu

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment Response in Advanced Lung Adenocarcinomas with G719X/L861Q/S768I Mutations

Cheng-Ta Yang, Chun-Ming Tsai, Chun-Liang Lai, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Jianying Zhou, Erdem Goker, Jun Zhao, 2019, The Lancet.

Should EGFR mutations be tested in advanced lung squamous cell carcinomas to guide frontline treatment?

Chun-Ming Tsai, Chi-Lu Chiang, T. Chou, 2014, Cancer Chemotherapy and Pharmacology.

Hypoxia inhibits senescence and maintains mesenchymal stem cell properties through down-regulation of E2A-p21 by HIF-TWIST.

C. Chiu, S. Hung, Tu‐Lai Yew, 2011, Blood.